Vertex Pharmaceuticals (VRTX) Earnings Date, Estimates & Call Transcripts → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free VRTX Stock Alerts $468.72 -3.79 (-0.80%) (As of 06/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 6EstimatedActual EPS (May. 6) $4.76 Beat By $1.10 Consensus EPS (May. 6) $3.66 Read Call TranscriptListen to Call Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVRTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Darwin2024 Crypto SecretsBitcoin has surged past $70,000. Are you prepared for what's next? Our free guide, "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024," is essential for staying ahead in the fast-evolving crypto market. It's crafted for both beginners and seasoned investors. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Click here to download your free report and start leading in the crypto race. Vertex Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$3.56$3.73$3.65 Q2 20242$3.57$3.81$3.69 Q3 20242$3.63$3.68$3.66 Q4 20242$3.67$4.08$3.88 FY 20248$14.43$15.30$14.87 Q1 20251$3.75$3.75$3.75 Q2 20251$3.99$3.99$3.99 Q3 20251$3.92$3.92$3.92 Q4 20251$3.99$3.99$3.99 FY 20254$15.65$15.65$15.65 Q1 20261$4.09$4.09$4.09 VRTX Earnings Date and InformationVertex Pharmaceuticals last posted its earnings data on May 6th, 2024. The pharmaceutical company reported $4.76 EPS for the quarter, topping analysts' consensus estimates of $3.66 by $1.10. The business had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.58 billion. Its revenue for the quarter was up 13.3% on a year-over-year basis. Vertex Pharmaceuticals has generated $15.41 earnings per share over the last year ($15.41 diluted earnings per share) and currently has a price-to-earnings ratio of 30.4. Earnings for Vertex Pharmaceuticals are expected to grow by 4.40% in the coming year, from $15.22 to $15.89 per share. Vertex Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off prior year's report dates.Read More Vertex Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/6/2024(Estimated)------- 5/6/2024Q1 2024$3.66$4.76+$1.10$4.37$2.58 billion$2.69 billion 2/5/2024Q4 2023$3.85$4.20+$0.35$3.43$2.50 billion$2.52 billion 11/6/2023Q3 2023$3.53$4.08+$0.55$3.37$2.50 billion$2.48 billion 8/1/2023Q2 2023$3.47$3.53+$0.06$3.54$2.41 billion$2.49 billion5/1/2023Q1 2023$2.51$3.05+$0.54$2.65$2.34 billion$2.37 billion 2/7/2023Q4 2022$3.11$3.76+$0.65$3.51$2.30 billion$2.30 billion $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge.10/27/2022Q3 2022$3.31$3.62+$0.31$3.65$2.23 billion$2.33 billion8/4/2022Q2 2022$3.05$3.25+$0.20$3.37$2.13 billion$2.20 billion 5/5/2022Q1 2022$3.17$3.16($0.01)$3.36$2.07 billion$2.10 billion 1/26/2022Q4 2021$2.91$3.18+$0.27$3.36$1.99 billion$2.07 billion 11/2/2021Q3 2021$2.74$3.56+$0.82$3.22$1.85 billion$1.98 billion 7/29/2021Q2 2021$2.25$3.11+$0.86$5.34$1.71 billion$1.79 billion 4/29/2021Q1 2021$2.38$2.98+$0.60$2.59$1.66 billion$1.72 billion 1/31/2021Q4 2020$2.59$2.51($0.08)$2.14$1.58 billion$1.63 billion 10/29/2020Q3 2020$1.96$2.64+$0.68$2.19$1.48 billion$1.54 billion 7/30/2020Q2 2020$1.75$2.61+$0.86$1.34$1.41 billion$1.52 billion 4/29/2020Q1 2020$1.84$2.56+$0.72$2.13$1.28 billion$1.52 billion 1/30/2020Q4 2019$1.21$1.70+$0.49$0.65$1.01 billion$1.41 billion 10/30/2019Q3 2019$0.87$1.23+$0.36$1.72$942.90 million$949.83 million 7/31/2019Q2 2019$0.75$0.99+$0.24$0.95$884.66 million$941.29 million Vertex Pharmaceuticals Earnings - Frequently Asked Questions When is Vertex Pharmaceuticals's earnings date? Vertex Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on VRTX's earnings history. Did Vertex Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vertex Pharmaceuticals (NASDAQ:VRTX) reported $4.76 earnings per share (EPS) to beat the analysts' consensus estimate of $3.66 by $1.10. Learn more on analysts' earnings estimate vs. VRTX's actual earnings. How can I listen to Vertex Pharmaceuticals's earnings conference call? The conference call for Vertex Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Vertex Pharmaceuticals's conference call transcript? The conference call transcript for Vertex Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded annual revenue of $9.87 billion. How much profit does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded net income of $3.62 billion. VRTX has generated $15.41 earnings per share over the last four quarters. What is Vertex Pharmaceuticals's price-to-earnings ratio? Vertex Pharmaceuticals (NASDAQ:VRTX) has a trailing price-to-earnings ratio of 30.42 and a forward price-to-earnings ratio of 30.80. The price/earnings-to-growth ratio is 2.41. What is Vertex Pharmaceuticals's EPS forecast for next year? Vertex Pharmaceuticals's earnings are expected to grow from $15.22 per share to $15.89 per share in the next year, which is a 4.40% increase. More Earnings Resources from MarketBeat Related Companies: AMGN Earnings Results REGN Earnings Results GILD Earnings Results BIIB Earnings Results ALNY Earnings Results RPRX Earnings Results BMRN Earnings Results UTHR Earnings Results NBIX Earnings Results BGNE Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: BlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings DropApple Stock All-Time Highs: Can AI Outweigh Earnings Jitters? This page (NASDAQ:VRTX) was last updated on 6/30/2024 by MarketBeat.com Staff From Our PartnersElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredWhere AI is REALLY Going NextBuying Nvidia was a good idea – twenty years ago when I first recommended it (for up to 37,000% gains). But...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump conviction scandal exposedIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the...Porter & Company | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Vertex Pharmaceuticals Incorporated You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.